‍TRUMBULL, Conn. and EL MONTE, Calif., Feb. 9, 2024 /PRNewswire/ -- CooperSurgical ®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (FLGT), a technology-based company ...

LOS ANGELES, Sept. 14, 2021 /PRNewswire/ -- Today, Generate Life Sciences announced a new milestone by enrolling 200,000 families in its Family Health Registry. This program is offered by Generate's ...

TRUMBULL, Conn., July 27, 2023 /PRNewswire/ -- CooperSurgical, a global leader in fertility and women's health, announced that Chrissy Teigen, mom, New York Times best-selling cookbook author, ...

For 14 years, Bristol obstetrician/gynecologist Dr. Alan L. Gorrell has offered his patients the option of collecting and saving stem cell-rich umbilical cord blood ...

LOS ANGELES, and EL SEGUNDO, Calif., Aug. 10, 2020 /PRNewswire/ -- CBR® by Generate Life Sciences, the world's largest private newborn stem cell bank, and NantKwest (Nasdaq: NK), a clinical-stage, ...

TRUMBULL, Conn., Sept. 8, 2023 /PRNewswire/ -- CooperSurgical, a global leader in fertility and women's health, announced that Cord Blood Registry ® (CBR ®) will have a key role in the upcoming Cord ...

Candidate: COVID-19 treatment based on newborn stem cells. Type: Research-donated, umbilical cord tissue-derived mesenchymal stem cells (MSCs) Status: Cord Blood Registry (CBR) and NantKwest said ...

San Bruno, CA—February 7, 2007—Cord Blood Registry® (CBR) today announced that it has completed initial validation testing of the company's proprietary CellAdvantageTM system using new automation ...

CHICAGO–(BUSINESS WIRE)–GTCR, a leading private equity firm, announced that it has completed the previously announced sale of its portfolio company Cord Blood Registry (“CBR” or the “Company”) to AMAG ...

SAN BRUNO, Calif.--(BUSINESS WIRE)--Cord Blood Registry (CBR), the world’s largest and most experienced cord blood stem cell bank, announced today that it has achieved record processings and ...

CHICAGO–(BUSINESS WIRE)–GTCR, a leading private equity firm, announced that it has completed the previously announced sale of its portfolio company Cord Blood Registry (“CBR” or the “Company”) to AMAG ...